Doximity (NYSE: DOCS) reported FQ1 results that topped analyst expectations, however, the lowered guidance sent shares tumbling in pre-market Wednesday.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE